4. #StarterNET: Ph 3, unressctable/recurrent non functional G1/2 GEP NET, 1L Lanreotide + everolimus vs everolimus
- Improved ORR (23% vs 8.3%)
- Improved PFS in all subsets w/ combo
- No OS difference at 1 year
5/8
0
0
1
0